| |
| |
|
| Insider
Information: |
Schreck Thomas A |
| Relationship: |
Director |
| City: |
Cupertino |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,175,649 |
|
|
Indirect Shares
|
957,982 |
|
|
| Direct
Value |
$2,064,996 |
|
|
|
Indirect Value
|
$894,303 |
|
|
| Total
Shares |
3,133,631 |
|
|
| Total
Value |
$2,959,299 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Durect Corp |
DRRX |
Chief Financial Office... |
2004-07-29 |
1,865,000 |
2004-07-29 |
940,000 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
Director |
2011-08-29 |
300,951 |
2011-08-29 |
17,982 |
Premium* |
|
|
Ekso Bionics Holdings, Inc. |
EKSO |
Director |
2020-07-23 |
9,698 |
2020-07-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EKSO |
Ekso Bionics Holdings, In... |
Director |
– • – |
2020-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,383 |
9,698 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-08-29 |
4 |
B |
$3.28 |
$1,640 |
I/I |
500 |
17,982 |
2.02 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-08-29 |
4 |
B |
$3.27 |
$1,634 |
D/D |
500 |
300,951 |
2.31 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-08-24 |
4 |
B |
$3.01 |
$3,010 |
I/I |
1,000 |
17,482 |
2.1 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-08-24 |
4 |
B |
$3.01 |
$3,010 |
D/D |
1,000 |
300,451 |
2.31 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
59,145 |
358,596 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
13,932 |
13,932 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
41,800 |
41,800 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-02-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,550 |
|
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Director |
– • – |
2011-02-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
257,651 |
|
- |
|
| DRRX |
Durect Corp |
Chief Financial Officer |
• • – |
2004-07-29 |
4 |
B |
$1.41 |
$2,115 |
D/D |
1,500 |
1,865,000 |
2.73 |
- |
|
| DRRX |
Durect Corp |
Chief Financial Officer |
• • – |
2004-07-28 |
4 |
B |
$1.39 |
$2,086 |
D/D |
1,500 |
1,863,500 |
2.73 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
